Arca
Skip to content

Rosacea

Drug research and approvals for rosacea: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 12 studies of rosacea are recruiting on ClinicalTrials.gov, Health Canada has authorized 6 drug trials for it since 2013, FDA has 1 approved and 0 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 12
  • Trials authorized in Canada: 6
  • FDA orphan approvals: 1
  • EU medicines: 1

Recruiting Now

Newest start dates first, of 12 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

Newest first; search them all in Canada trials
May 20, 2026A multicenter, randomized, double-blind, placebo-controlled phase 2 study to investigate the efficacy, safety and tolerability of remibrutinib (lou064) in…REMIBRUTINIB (LOU064)Novartis Pharmaceuticals CorporationOngoing
May 3, 2017Efficacy comparison of ivermectin 1% topical cream associated with doxycycline 40 mg modified release (mr) capsules versus ivermectin 1% topical cream…IVERMECTIN/ DOXYCYCLINEGALDERMA CANADA INCClosed
Sep 28, 2015A phase 3 open-label extension study to evaluate the long-term safety of omiganan topical gel in subjects with rosaceaOMIGANANCUTANEA LIFE SCIENCES, INCClosed
Sep 28, 2015A phase 3, randomized, vehicle-controlled, double-blind, multicenter study to evaluate the safety and efficacy of a once-daily cls001 topical gel versus…OMIGANANCUTANEA LIFE SCIENCES, INCClosed
Sep 28, 2015A phase 3, randomized, vehicle-controlled, double-blind, multicenter study to evaluate the safety and efficacy of a once-daily cls001 topical gel versus…OMIGANANCUTANEA LIFE SCIENCES, INCClosed
Oct 8, 2013A randomized, double-blind, vehicle controlled study of the safety and efficacy of topical drm02 in subjects with rosaceaDRM02DERMIRA INCORPORATEDClosed

FDA Orphan Designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Nov 22, 1988MetrogelTreatment of acne rosacea.Galderma Laboratories, Inc.Approved

Medicines Authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Feb 20, 2014MirvasobrimonidineGalderma S.A. (Netherlands Branch)EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.